Trevi Therapeutics Announces Two Posters from the Phase 2a RIVER Trial Data Will be Featured at the European Respiratory Society (ERS) Congress 2025

Stock Information for Trevi Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Trevi Therapeutics Inc.

Trevi Therapeutics Announces Appointment of David Hastings as Chief Financial Officer
Trevi Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
Trevi Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 13, 2025
Trevi Therapeutics to Participate in Stifel 2025 Healthcare Conference
Trevi Therapeutics Announces Oral Presentation and Abstracts at CHEST 2025 Annual Meeting
Trevi Therapeutics to Participate in Upcoming September Conferences
Trevi Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates
Trevi Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Corporate Update on August 7, 2025

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.